To hear about similar clinical trials, please enter your email below
Trial Title:
Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
NCT ID:
NCT00164918
Condition:
Cancer of Stomach
Conditions: Official terms:
Stomach Neoplasms
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Unknown status
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Device
Intervention name:
nasogastric tube
Summary:
The aim of the study is to evaluate whether subtotal gastrectomy without post-operative
nasogastric decompression is better in terms of early post-operative bowel function and
chest complication.
Detailed description:
Nasogastric decompression is an intra-operative routine in most of the time to facilitate
exposure of operative field during elective subtotal gastrectomy, but whether it should
be retained post-operatively is controversial. Nasogastric decompression helps to drain
the gastric remnant in case there is edema around the gastrojejunostomy, ileus and
delayed gastric emptying, which can theoretically relieve nausea and abdominal
distension. Besides, it may help decrease diaphragmatic splintage and hence decrease
chance of chest infection if ileus occurs. However, nasogastric intubation could cause
patient discomfort; also it has been shown that it would cause gastroesophageal reflux
which may be associated with chest complication. There have been studies showing that
routine post-operative nasogastric decompression is not necessary for gastrectomy in
general, but the role in subtotal gastrectomy for stomach cancer is not well defined.
Criteria for eligibility:
Criteria:
Inclusion Criteria:All patients suffering from carcinoma of stomach, decided for
operation
- subtotal, D1/D2 dissection
- palliative resection
Exclusion Criteria:
- actively bleeding tumor
- perforation of tumor
- patient present with gastric outlet obstruction
- combine organ excision
- known diabetes with nephropathy
Gender:
All
Minimum age:
18 Weeks
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Surgical Ward, Prince of Wales Hospital
Address:
City:
Hong Kong
Country:
China
Status:
Recruiting
Contact:
Last name:
Enders K.W. Ng, MD
Phone:
85226322627
Email:
endersng@surgery.cuhk.edu.hk
Contact backup:
Last name:
Man Yee Yung, BN
Phone:
85226322956
Email:
myyung@surgery.cuhk.edu.hk
Investigator:
Last name:
Chris K.W. Yau, MRCS (Ed)
Email:
Sub-Investigator
Investigator:
Last name:
Enders K.W. Ng, MD
Email:
Principal Investigator
Start date:
September 2004
Lead sponsor:
Agency:
Chinese University of Hong Kong
Agency class:
Other
Source:
Chinese University of Hong Kong
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00164918
